Disc Medicine Inc. Insider Trading
IRON
Insiders sold $48.8M and bought nothing on the open market.
58% of the selling was scheduled in advance under 10b5-1 plans. Director Kevin Bitterman sold $16.9M on Dec 16, 2025, 34% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2024.
Get an email when IRON's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10 | William Jacob Savage Chief Medical Officer | Sold10b5-1 plan | 16,035 | $85.09 | $1.36M | 20% | Form 4 |
| Oct 19 – 21 | Kevin Bitterman Director | Sold10b5-1 plan 9 parts | 41,825 | $80.13 average | $3.35M | 76% | Form 4 |
| Sep 11 | Kevin Bitterman Director | SoldNo plan | 27,136 | $70.11 | $1.9M | 8.0% | Form 4 |
| Sep 4 | Kevin Bitterman Director | Sold10b5-1 plan 3 parts | 1,689 | $79.96 average | 135K | 11% | Form 4 |
| Sep 1 – 3 | Kevin Bitterman Director | Sold10b5-1 plan 12 parts | 54,496 | $80.15 average | $4.37M | 80% | Form 4 |
| Aug 24 – 25 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan 2 parts | 9,096 | $83.10 average | 756K | 14% | Form 4 |
| Aug 17 | John D Quisel Chief Executive Officer | Sold10b5-1 plan 3 parts | 33,000 | $79.15 average | $2.61M | 13% | Form 4 |
| Aug 12 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan | 804 | $82.64 | 66K | 1.5% | Form 4 |
| Aug 6 | Rahul Khara Chief Legal Officer | Sold10b5-1 plan | 5,000 | $80.00 | 400K | 8.7% | Form 4 |
| Jul 13 | John D Quisel Chief Executive Officer | Sold10b5-1 plan 3 parts | 33,000 | $74.96 average | $2.47M | 13% | Form 4 |
| Jul 7 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan | 100 | $82.50 | 8K | 0.2% | Form 4 |
| Jun 26 – 29 | Rahul Khara Chief Legal Officer | Sold10b5-1 plan 2 parts | 2,500 | $75.00 average | 188K | 4.6% | Form 4 |
| Jun 26 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan | 300 | $72.50 | 22K | 0.5% | Form 4 |
| Jun 22 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan | 9,700 | $72.66 | 705K | 15% | Form 4 |
| Jun 18 | Rahul Khara Chief Legal Officer | Sold10b5-1 plan 3 parts | 7,500 | $70.22 average | 527K | 13% | Form 4 |
| Jun 18 | John D Quisel Chief Executive Officer | Sold10b5-1 plan 3 parts | 34,000 | $70.22 average | $2.39M | 13% | Form 4 |
| Jun 16 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan 2 parts | 18,612 | $69.19 average | $1.29M | 26% | Form 4 |
| Apr 13 – 14 | Jean M. Franchi Chief Financial Officer | Sold10b5-1 plan 2 parts | 6,657 | $69.23 average | 461K | 9.4% | Form 4 |
| Apr 13 | William Jacob Savage Chief Medical Officer | Sold10b5-1 plan 2 parts | 5,731 | $66.38 average | 380K | 6.7% | Form 4 |
| Mar 2 | William Jacob Savage Chief Medical Officer | Sold10b5-1 plan 2 parts | 7,378 | $65.88 average | 486K | 8.0% | Form 4 |
| Feb 25 | Jean M. Franchi Chief Financial Officer | Sold10b5-1 plan | 353 | $69.06 | 24K | 0.5% | Form 4 |
| Feb 17 – 18 | Jean M. Franchi Chief Financial Officer | Sold10b5-1 plan 3 parts | 11,156 | $64.52 average | 720K | 14% | Form 4 |
| Feb 17 | Rahul Khara Chief Legal Officer | SoldNo plan | 2,853 | $62.86 | 179K | 5.2% | Form 4 |
| Feb 17 | Pamela Stephenson Chief Commercial Officer | SoldNo plan | 5,531 | $62.86 | 348K | 6.4% | Form 4 |
| Feb 17 | William Jacob Savage Chief Medical Officer | SoldNo plan | 3,256 | $62.86 | 205K | 3.4% | Form 4 |
| Feb 17 | Jonathan Yen-Wen Yu Chief Operating Officer | SoldNo plan | 3,231 | $62.86 | 203K | 5.6% | Form 4 |
| Feb 17 | John D Quisel Chief Executive Officer | SoldNo plan | 13,264 | $62.86 | 834K | 5.5% | Form 4 |
| Jan 20 | Rahul Khara Chief Legal Officer | Sold10b5-1 plan | 1,000 | $69.74 | 70K | 2.6% | Form 4 |
| Jan 2 | Rahul Khara Chief Legal Officer | Sold10b5-1 plan 3 parts | 6,500 | $78.68 average | 511K | 15% | Form 4 |
| Dec 17, 2025 | Kevin Bitterman Director | SoldNo plan 3 parts | 754 | $91.47 average | 69K | 5.1% | Form 4 |
| Dec 12, 2025 – Dec 16, 2025 | Kevin Bitterman Director | SoldNo plan 19 parts | 184,123 | $91.56 average | $16.9M | 34% | Form 4 |
| Dec 15, 2025 | William Jacob Savage Chief Medical Officer | Sold10b5-1 plan 3 parts | 13,093 | $91.22 average | $1.19M | 15% | Form 4 |
| Dec 11, 2025 | John D Quisel Chief Executive Officer | Sold10b5-1 plan 4 parts | 40,000 | $93.05 average | $3.72M | 19% | Form 4 |
| Nov 11, 2025 | Jonathan Yen-Wen Yu Chief Operating Officer | Sold10b5-1 plan 4 parts | 30,000 | $84.70 average | $2.54M | 43% | Form 4 |
| Oct 22, 2025 | AI DMI LLC Large holder | SoldNo plan | 744,047 | $80.47 | $59.9M | 21% | Form 4 |
| Oct 15, 2025 – Oct 17, 2025 | Kevin Bitterman Director | SoldNo plan 17 parts | 93,585 | $85.97 average | $8.05M | 20% | Form 4 |
| Oct 7, 2025 – Oct 8, 2025 | Kevin Bitterman Director | SoldNo plan 7 parts | 90,000 | $70.14 average | $6.31M | 15% | Form 4 |
| Aug 22, 2025 | Kevin Bitterman Director | Sold10b5-1 plan | 2,287 | $61.03 | 140K | 0.4% | Form 4 |
| Aug 13, 2025 – Aug 14, 2025 | Kevin Bitterman Director | Sold10b5-1 plan 2 parts | 32,174 | $61.11 average | $1.97M | 5.1% | Form 4 |
| Aug 5, 2025 | Kevin Bitterman Director | Sold10b5-1 plan | 395 | $60.95 | 24K | <0.1% | Form 4 |
- Nov 1010b5-1 planWilliam Jacob SavageChief Medical Officer · sold 16,035 at $85.09$1.36M20% of stake
- Oct 19 – 2110b5-1 planKevin BittermanDirector · sold 41,825 at avg $80.13$3.35M76% of stake
- Sep 11No planKevin BittermanDirector · sold 27,136 at $70.11$1.9M8.0% of stake
- Sep 410b5-1 planKevin BittermanDirector · sold 1,689 at avg $79.96135K11% of stake
- Sep 1 – 310b5-1 planKevin BittermanDirector · sold 54,496 at avg $80.15$4.37M80% of stake
- Aug 24 – 2510b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 9,096 at avg $83.10756K14% of stake
- Aug 1710b5-1 planJohn D QuiselChief Executive Officer · sold 33,000 at avg $79.15$2.61M13% of stake
- Aug 1210b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 804 at $82.6466K1.5% of stake
- Aug 610b5-1 planRahul KharaChief Legal Officer · sold 5,000 at $80.00400K8.7% of stake
- Jul 1310b5-1 planJohn D QuiselChief Executive Officer · sold 33,000 at avg $74.96$2.47M13% of stake
- Jul 710b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 100 at $82.508K0.2% of stake
- Jun 26 – 2910b5-1 planRahul KharaChief Legal Officer · sold 2,500 at avg $75.00188K4.6% of stake
- Jun 2610b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 300 at $72.5022K0.5% of stake
- Jun 2210b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 9,700 at $72.66705K15% of stake
- Jun 1810b5-1 planRahul KharaChief Legal Officer · sold 7,500 at avg $70.22527K13% of stake
- Jun 1810b5-1 planJohn D QuiselChief Executive Officer · sold 34,000 at avg $70.22$2.39M13% of stake
- Jun 1610b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 18,612 at avg $69.19$1.29M26% of stake
- Apr 13 – 1410b5-1 planJean M. FranchiChief Financial Officer · sold 6,657 at avg $69.23461K9.4% of stake
- Apr 1310b5-1 planWilliam Jacob SavageChief Medical Officer · sold 5,731 at avg $66.38380K6.7% of stake
- Mar 210b5-1 planWilliam Jacob SavageChief Medical Officer · sold 7,378 at avg $65.88486K8.0% of stake
- Feb 2510b5-1 planJean M. FranchiChief Financial Officer · sold 353 at $69.0624K0.5% of stake
- Feb 17 – 1810b5-1 planJean M. FranchiChief Financial Officer · sold 11,156 at avg $64.52720K14% of stake
- Feb 17No planRahul KharaChief Legal Officer · sold 2,853 at $62.86179K5.2% of stake
- Feb 17No planPamela StephensonChief Commercial Officer · sold 5,531 at $62.86348K6.4% of stake
- Feb 17No planWilliam Jacob SavageChief Medical Officer · sold 3,256 at $62.86205K3.4% of stake
- Feb 17No planJonathan Yen-Wen YuChief Operating Officer · sold 3,231 at $62.86203K5.6% of stake
- Feb 17No planJohn D QuiselChief Executive Officer · sold 13,264 at $62.86834K5.5% of stake
- Jan 2010b5-1 planRahul KharaChief Legal Officer · sold 1,000 at $69.7470K2.6% of stake
- Jan 210b5-1 planRahul KharaChief Legal Officer · sold 6,500 at avg $78.68511K15% of stake
- Dec 17, 2025No planKevin BittermanDirector · sold 754 at avg $91.4769K5.1% of stake
- Dec 12, 2025 – Dec 16, 2025No planKevin BittermanDirector · sold 184,123 at avg $91.56$16.9M34% of stake
- Dec 15, 202510b5-1 planWilliam Jacob SavageChief Medical Officer · sold 13,093 at avg $91.22$1.19M15% of stake
- Dec 11, 202510b5-1 planJohn D QuiselChief Executive Officer · sold 40,000 at avg $93.05$3.72M19% of stake
- Nov 11, 202510b5-1 planJonathan Yen-Wen YuChief Operating Officer · sold 30,000 at avg $84.70$2.54M43% of stake
- Oct 22, 2025No planAI DMI LLCLarge holder · sold 744,047 at $80.47$59.9M21% of stake
- Oct 15, 2025 – Oct 17, 2025No planKevin BittermanDirector · sold 93,585 at avg $85.97$8.05M20% of stake
- Oct 7, 2025 – Oct 8, 2025No planKevin BittermanDirector · sold 90,000 at avg $70.14$6.31M15% of stake
- Aug 22, 202510b5-1 planKevin BittermanDirector · sold 2,287 at $61.03140K0.4% of stake
- Aug 13, 2025 – Aug 14, 202510b5-1 planKevin BittermanDirector · sold 32,174 at avg $61.11$1.97M5.1% of stake
- Aug 5, 202510b5-1 planKevin BittermanDirector · sold 395 at $60.9524K<0.1% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with IRON
Held by ETFs
IRON is in 42 US ETFs. The largest of them, with IRON's weight in each:
Spot a number that looks wrong? Check it in IRON's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing IRON
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.